X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (61767) 61767
Newspaper Article (7713) 7713
Newsletter (4456) 4456
Magazine Article (1147) 1147
Book Chapter (353) 353
Trade Publication Article (173) 173
Book / eBook (153) 153
Web Resource (130) 130
Dissertation (106) 106
Transcript (97) 97
Conference Proceeding (59) 59
Book Review (56) 56
Government Document (53) 53
Publication (33) 33
Reference (26) 26
Streaming Video (24) 24
Report (8) 8
Journal / eJournal (3) 3
Video Recording (3) 3
Pamphlet (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
osteoporosis (57297) 57297
humans (41071) 41071
female (31018) 31018
middle aged (18077) 18077
aged (17274) 17274
male (16419) 16419
fractures (14100) 14100
bone density (13310) 13310
endocrinology & metabolism (12256) 12256
risk factors (11064) 11064
postmenopausal women (10812) 10812
bones (9832) 9832
adult (9487) 9487
osteoporosis - drug therapy (9128) 9128
women (8721) 8721
research (8581) 8581
animals (8133) 8133
orthopedics (7803) 7803
density (7327) 7327
health aspects (6760) 6760
bone mineral density (6646) 6646
bone density - drug effects (6634) 6634
bone-mineral density (6580) 6580
aged, 80 and over (6497) 6497
medicine & public health (6422) 6422
drug therapy (6364) 6364
care and treatment (6228) 6228
rheumatology (5768) 5768
risk (5616) 5616
prevention (5539) 5539
bone density conservation agents - therapeutic use (4942) 4942
mineral density (4728) 4728
analysis (4653) 4653
hormone replacement therapy (4543) 4543
osteoporosis, postmenopausal - drug therapy (4531) 4531
endocrinology (4516) 4516
menopause (4418) 4418
osteoporosis - prevention & control (4288) 4288
osteoporosis - etiology (4217) 4217
medicine, general & internal (4180) 4180
absorptiometry, photon (4112) 4112
osteoporosis - complications (4012) 4012
therapy (3911) 3911
bone (3763) 3763
alendronate (3704) 3704
bisphosphonates (3675) 3675
vitamin d (3647) 3647
hip fracture (3637) 3637
bone density - physiology (3542) 3542
treatment outcome (3537) 3537
rats (3504) 3504
estrogen (3411) 3411
fracture (3391) 3391
diphosphonates - therapeutic use (3379) 3379
womens health (3319) 3319
metabolism (3279) 3279
medical research (3236) 3236
osteoporosis - diagnosis (3228) 3228
diagnosis (3161) 3161
calcium (3136) 3136
osteoporosis - physiopathology (3080) 3080
osteoporosis - therapy (3060) 3060
postmenopausal osteoporosis (2946) 2946
mass (2793) 2793
physiological aspects (2772) 2772
age (2758) 2758
adolescent (2635) 2635
prevalence (2628) 2628
osteoporosis, postmenopausal - prevention & control (2616) 2616
medicine (2612) 2612
osteoporosis - epidemiology (2609) 2609
bone and bones - metabolism (2598) 2598
men (2581) 2581
mice (2528) 2528
patients (2528) 2528
pharmacology & pharmacy (2489) 2489
ovariectomy (2463) 2463
cancer (2446) 2446
disease (2405) 2405
osteoporosis - chemically induced (2403) 2403
studies (2398) 2398
older people (2387) 2387
time factors (2368) 2368
surgery (2360) 2360
medicine, experimental (2356) 2356
bone loss (2325) 2325
prospective studies (2285) 2285
fractures, bone - prevention & control (2277) 2277
epidemiology (2258) 2258
internal medicine (2257) 2257
medicine, research & experimental (2244) 2244
osteoporosis - metabolism (2209) 2209
risk assessment (2183) 2183
drugs (2178) 2178
retrospective studies (2166) 2166
follow-up studies (2164) 2164
estrogen replacement therapy (2157) 2157
complications and side effects (2150) 2150
fractures, bone - etiology (2131) 2131
spine (2094) 2094
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (75) 75
Online Resources - Online (58) 58
Collection Dvlpm't (Acquisitions) - Vendor file (13) 13
New College (Ivey) - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Providence Healthcare - Stacks (4) 4
Sunnybrook Health Sciences Centre - Holland Stacks (4) 4
Baycrest Hospital - Wellness Library (3) 3
Scarborough Hospital - Online (3) 3
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Media Commons - Audio Visual (2) 2
Scarborough Hospital - Birchmount (2) 2
St. Michael's Hospital - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Periodical Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Robarts - Processing (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (70446) 70446
German (1922) 1922
Japanese (1162) 1162
French (1034) 1034
Spanish (520) 520
Russian (310) 310
Chinese (303) 303
Italian (300) 300
Polish (268) 268
Portuguese (141) 141
Czech (103) 103
Danish (94) 94
Korean (92) 92
Dutch (81) 81
Hungarian (72) 72
Turkish (68) 68
Swedish (60) 60
Croatian (56) 56
Norwegian (47) 47
Finnish (45) 45
Slovak (39) 39
Serbian (22) 22
Hebrew (18) 18
Bulgarian (16) 16
Romanian (11) 11
Ukrainian (8) 8
Slovenian (7) 7
Lithuanian (5) 5
Persian (4) 4
Arabic (3) 3
Greek (2) 2
Bosnian (1) 1
Estonian (1) 1
Georgian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Rheumatology (Oxford, England), ISSN 1462-0332, 2019, Volume 58, Issue Supplement_1, pp. i43 - i54
Abstract Janus kinase (JAK)/signal transducers and activators of transcription (STATs) are a group of molecules associated with one of the major pathways... 
FILGOTINIB GLPG0634/GS-6034 | CROHNS-DISEASE | INADEQUATE RESPONSE | PHASE-III | STAT pathway | RHEUMATOLOGY | LONG-TERM EXTENSION | ALOPECIA-AREATA | immune-mediated diseases | CHRONIC PLAQUE PSORIASIS | JAK | JANUS KINASE INHIBITOR | DOUBLE-BLIND | JAK inhibitors | TOFACITINIB-TREATED PATIENTS | Spondylarthropathies - drug therapy | Chilblains - drug therapy | Humans | Dental Enamel Hypoplasia - drug therapy | Metacarpus - abnormalities | Osteoporosis - drug therapy | Immunologic Deficiency Syndromes | Arthritis, Rheumatoid - drug therapy | Lupus Erythematosus, Cutaneous - drug therapy | Arthritis, Psoriatic - drug therapy | Muscular Diseases - drug therapy | Autoimmune Diseases - drug therapy | Inflammatory Bowel Diseases - drug therapy | Psoriasis - drug therapy | Cytokines | Uveitis - drug therapy | Giant Cell Arteritis - drug therapy | Vascular Calcification - drug therapy | Autoimmune Diseases of the Nervous System - drug therapy | Aortic Diseases - drug therapy | Dermatitis, Atopic - drug therapy | Alopecia Areata - drug therapy | Janus Kinase Inhibitors - therapeutic use | Odontodysplasia - drug therapy | Nervous System Malformations - drug therapy | Phosphorylation | Transcription factors | Transcription | Clinical trials | Inflammation | Immunosuppressive agents | Signal transduction | Alopecia | Atopic dermatitis | Rheumatoid arthritis | Janus kinase | Skin diseases | Transduction | Growth factors | Reviews
Journal Article
Journal of Crohn's and colitis, ISSN 1876-4479, 2016, Volume 10, Issue 3, pp. 239 - 254
Manifestations | Evidence-Based Consensus | Crohn's disease | ECCO | Inflammatory Bowel Disease | European | Extra-intestinal manifestation | Ulcerative colitis | Inflammatory bowel disease | ulcerative colitis | GASTROENTEROLOGY & HEPATOLOGY | extra-intestinal manifestation | inflammatory bowel disease | Osteoporosis - therapy | Pancreatitis - etiology | Humans | Osteoporosis - diagnosis | Arthritis - diagnosis | Cardiovascular Diseases - therapy | Female Urogenital Diseases - etiology | Male | Lung Diseases - therapy | Nervous System Diseases - diagnosis | Osteoporosis - etiology | Lung Diseases - etiology | Otorhinolaryngologic Diseases - therapy | Skin Diseases - diagnosis | Liver Diseases - etiology | Arthritis - etiology | Female Urogenital Diseases - diagnosis | Male Urogenital Diseases - therapy | Female | Inflammatory Bowel Diseases - complications | Otorhinolaryngologic Diseases - etiology | Cardiovascular Diseases - diagnosis | Cardiovascular Diseases - etiology | Female Urogenital Diseases - therapy | Skin Diseases - therapy | Pancreatitis - therapy | Lung Diseases - diagnosis | Eye Diseases - etiology | Liver Diseases - therapy | Cholangitis, Sclerosing - etiology | Male Urogenital Diseases - diagnosis | Eye Diseases - diagnosis | Nervous System Diseases - therapy | Pancreatitis - diagnosis | Skin Diseases - etiology | Male Urogenital Diseases - etiology | Cholangitis, Sclerosing - therapy | Nervous System Diseases - etiology | Liver Diseases - diagnosis | Cholangitis, Sclerosing - diagnosis | Arthritis - therapy | Otorhinolaryngologic Diseases - diagnosis | Eye Diseases - therapy | ECCO Guideline | Consensus Paper | Crohn’s disease
Journal Article
Journal Article
Osteoporosis International, ISSN 0937-941X, 3/2012, Volume 23, Issue 3, pp. 797 - 809
.... Choice of osteoporosis therapy should be individualized based on consideration of the efficacy, safety, cost, convenience (i.e... 
Osteoporosis | Selective estrogen receptor modulator | Medicine & Public Health | Orthopedics | Gynecology | Rheumatology | Postmenopause | Fracture | Drug therapy | Bisphosphonates | Endocrinology | BONE-MINERAL DENSITY | NONVERTEBRAL FRACTURES | STRONTIUM RANELATE | HORMONE REPLACEMENT THERAPY | CONJUGATED EQUINE ESTROGEN | BREAST-CANCER | BAZEDOXIFENE/CONJUGATED ESTROGENS | VERTEBRAL FRACTURE RISK | ENDOCRINOLOGY & METABOLISM | POSTMENOPAUSAL WOMEN | INITIATIVE RANDOMIZED-TRIAL | Thiophenes - therapeutic use | Teriparatide - therapeutic use | Humans | Middle Aged | Osteoporotic Fractures - prevention & control | Bone Density Conservation Agents - therapeutic use | Antibodies, Monoclonal - therapeutic use | Calcitonin - therapeutic use | Denosumab | Osteoporosis, Postmenopausal - drug therapy | Antibodies, Monoclonal, Humanized | Estrogen Replacement Therapy - methods | Diphosphonates - therapeutic use | Organometallic Compounds - therapeutic use | Female | Aged | Precision Medicine - methods | Hormone therapy | Diphosphonates | Postmenopausal women | Research | Health aspects | Decision making | Drugs | selective estrogen receptor modulators | Vertebrae | Benign | Estrogen receptors | Hormones | Hip | Risk factors | Post-menopause | Strontium | Renal insufficiency | Fractures | Parathyroid hormone | Calcitonin | Risk assessment | Monoclonal antibodies | Geriatrics
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, p. e0166367
Background Annually, non-communicable diseases (NCDs) kill 38 million people worldwide, with low and middle-income countries accounting for three-quarters of... 
INSTRUMENT | APPRAISAL | PRIMARY-CARE | MANAGEMENT | AGREE II | CHINA | MULTIDISCIPLINARY SCIENCES | MULTIMORBIDITY | Gastroesophageal Reflux - therapy | Osteoporosis - therapy | Humans | Male | Gastroesophageal Reflux - epidemiology | Dementia - epidemiology | Pulmonary Disease, Chronic Obstructive - epidemiology | Osteoarthritis - therapy | Prostatic Hyperplasia - epidemiology | Heart Failure - therapy | Osteoarthritis - epidemiology | Hypercholesterolemia - therapy | Hypertension - epidemiology | Hypertension - therapy | Heart Failure - epidemiology | Brazil - epidemiology | Asthma - epidemiology | Hypercholesterolemia - epidemiology | Osteoporosis - epidemiology | Angina, Stable - therapy | Depression - epidemiology | Atrial Fibrillation - therapy | Dementia - therapy | Prostatic Hyperplasia - therapy | Pulmonary Disease, Chronic Obstructive - therapy | Coronary Artery Disease - therapy | Atrial Fibrillation - epidemiology | Angina, Stable - epidemiology | Asthma - therapy | Coronary Artery Disease - epidemiology | Depression - therapy | Practice Guidelines as Topic | Heart failure | Hypertension | Gastroesophageal reflux | Heart | Care and treatment | Communicable diseases | Atrial fibrillation | Angina pectoris | Osteoporosis | Hypercholesterolemia | Medical care | Antiarthritic agents | Respiratory tract diseases | Osteoarthritis | Dementia | Quality management | Health care | Transparency | Accounting | Hyperplasia | Cardiovascular disease | Systematic review | Angina | Congestive heart failure | Mental depression | Guidelines | Literature reviews | Biomedical materials | Fibrillation | Quality | Dementia disorders | Biocompatibility | Chronic obstructive pulmonary disease | Libraries | Pharmaceutical sciences | Public health | CpG islands | Chronic illnesses | Adaptation | Medical personnel | Decision making | Diabetes mellitus | Lung diseases | Coronary artery | Pharmacology | Coronary artery disease | Clarity | Asthma | Studies | Collaboration | Rheumatoid arthritis | Pharmacy | Obstructive lung disease | Clinical medicine | Quality assessment
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 3, pp. 209 - 219
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 361, Issue 8, pp. 745 - 755
Men receiving androgen-deprivation therapy for nonmetastatic prostate cancer are at high risk for bone loss and fractures... 
ZOLEDRONIC ACID | FRACTURE | MEDICINE, GENERAL & INTERNAL | PLACEBO | BONE-MINERAL DENSITY | RISK | COMPLICATIONS | RANDOMIZED CONTROLLED-TRIAL | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | ALENDRONATE | Lumbar Vertebrae - injuries | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Male | Osteoporosis - drug therapy | Prostatic Neoplasms - physiopathology | Bone Remodeling - drug effects | Incidence | Antibodies, Monoclonal, Humanized | Spinal Fractures - prevention & control | RANK Ligand - pharmacology | Injections, Subcutaneous | Aged, 80 and over | RANK Ligand - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Lumbar Vertebrae - physiology | Prostatic Neoplasms - drug therapy | RANK Ligand - adverse effects | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Prostatic Neoplasms - surgery | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Lumbar Vertebrae - drug effects | Denosumab | Bone Density Conservation Agents - pharmacology | Orchiectomy | Bone Density - drug effects | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Fractures, Bone - prevention & control | Osteoporosis | Bone density | Prostate cancer | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article